SCHEMBL7636623

SCHEMBL7636623

CC(NCC1CCCCC1)C(O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.49
CYP2D6 P10635 2/20 0.49
CYP2C19 P33261 2/20 0.49
CHRM2 P08172 1/20 0.49
ADRA1A P35348 1/20 0.49
RGS12 O14924 1/20 0.49
GLA P06280 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
PKM P14618 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
ALOX12 P18054 1/20 0.49
ADRA2C P18825 1/20 0.49
NFKB1 P19838 1/20 0.49
HTR2A P28223 1/20 0.49
THPO P40225 1/20 0.49
GNAI1 P63096 1/20 0.49
HSD17B10 Q99714 1/20 0.49
NPSR1 Q6W5P4 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7636630 1.00 LMNA (0.49) LMNACYP2D6CYP2C19CHRM2ADRA1A
SCHEMBL3681375 0.82 GAA (0.61) LMNACYP2D6CYP2C19CHRM2ADRA1A
SCHEMBL3681373 0.82 GAA (0.61) LMNACYP2D6CYP2C19CHRM2ADRA1A
Bicarbonate SCHEMBL11119101 0.77 BCHE (0.54) NPSR1MEN1KMT2ABCHEOPRK1
SCHEMBL20144709 0.76 GAA (0.62) LMNACYP2D6CYP2C19CHRM2ADRA1A
Ephedrine SCHEMBL28142813 0.75 CYP2D6 (0.61) LMNACYP2D6CYP2C19CHRM2ADRA1A
Alifedrine SCHEMBL2108978 0.75 SLC6A4 (0.49) LMNACYP2D6CYP2C19CHRM2ADRA1A
SCHEMBL8751273 0.75 CYP1A2 (0.60) LMNACYP2D6CYP2C19CHRM2ADRA1A
SCHEMBL16067322 0.75 NPC1 (0.52) NPSR1MEN1KMT2ABCHEOPRK1
SCHEMBL11065754 0.75 HTT (0.39) CYP2D6HTTMEN1KMT2ASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020193347-A1 Using an optically active N-substituted chiral derivative of norephedrine as ligand for enantioselective reduction of unsaturated compounds carrying functional groups by a hydrogen transfer method PPG-SIPSY, A CORPORATION OF FRANCE (FR) 2002-12-19 US disclosed